UBE2S and ovarian carcinoma: The results in Fig. 10 suggested that the knockdown of UBE2S may regulate the expression levels of cell cycle signature proteins (CDK1 and Cyclin E1) and then arrest the cell cycle of ovarian cancer cells in the G2 phase.